Prime Medicine announces recent progress and highlights 2023 strategic priorities
New preclinical data in Friedrich’s ataxia and cystic fibrosis provided further proof-of-concept for Prime Editing’s ability to achieve ...
News & Blog
News & Blog
Hereditary Ataxias Added as Eligible Condition for CDMRP Funding!
Meet The Community: Hamilton Family
Meet The Community: Hüseyin
Design Therapeutics Reports Positive Data from Single-Ascending Dose Trial of DT-216 for the Treatment of Friedreich Ataxia and Portfolio Progress
Meet The Community: Katherine O’Connor
Meet The Community: Andrea Kiess
Meet The Community: Muhammad
Meet The Community: Marzia
Meet The Community: Edanur Sekmen
Meet The Community: Omega A. Urban
